A Phase IIb Study of Nabiximols for Spasticity Due to Neuromyelitis Optica Spectrum Disorders
Condition(s):NMO Spectrum Disorder; Spasticity, MuscleLast Updated:November 18, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):NMO Spectrum Disorder; Spasticity, MuscleLast Updated:November 18, 2023Not yet recruiting
Condition(s):Post-Traumatic Stress DisorderLast Updated:June 3, 2022Withdrawn
Condition(s):Spasticity With Multiple SclerosisLast Updated:February 5, 2024Terminated
Condition(s):Spasticity in Participants With Multiple SclerosisLast Updated:July 20, 2023Completed
Condition(s):Multiple Sclerosis (MS)Last Updated:March 10, 2023Terminated
Condition(s):Pain; Advanced CancerLast Updated:April 12, 2023Completed
Condition(s):Tourette Syndrome; Tic DisordersLast Updated:December 10, 2020Completed
Condition(s):Pain; Advanced CancerLast Updated:April 12, 2023Completed
Condition(s):Pain; Advanced CancerLast Updated:April 12, 2023Completed
Condition(s):Pain; Advanced CancerLast Updated:April 23, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.